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Abstract
Light-activatable proteins allow precise spatial and temporal control of biological processes
in living cells and animals. Several approaches have been developed for controlling protein
localization with light, including the conditional inhibition of a nuclear localization signal
(NLS) with the Light Oxygen Voltage (AsLOV2) domain of phototropin 1 from Avena sativa.
In the dark, the switch adopts a closed conformation that sterically blocks the NLS motif.
Upon activation with blue light the C-terminus of the protein unfolds, freeing the NLS to di-
rect the protein to the nucleus. A previous study showed that this approach can be used to
control the localization and activity of proteins in mammalian tissue culture cells. Here, we
extend this result by characterizing the binding properties of a LOV/NLS switch and demon-
strating that it can be used to control gene transcription in yeast. Additionally, we show that
the switch, referred to as LANS (light-activated nuclear shuttle), functions in the C. elegans
embryo and allows for control of nuclear localization in individual cells. By inserting LANS
into the C. elegans lin-1 locus using Cas9-triggered homologous recombination, we demon-
strated control of cell fate via light-dependent manipulation of a native transcription factor.
We conclude that LANS can be a valuable experimental method for spatial and temporal
control of nuclear localization in vivo.
Introduction
Many biological processes rely on the precise spatial segregation of macromolecules within a
living cell. Regulated compartmental partitioning is a common mechanism for controlling
gene expression through sequestering transcription factors in the cytoplasm [1]. Analogously,
inducible nucleocytoplasmic translocation represents a powerful approach to control cell
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behavior by conditionally removing a protein of interest from the cellular compartment where
it is active. We sought to generate a single component, genetically encoded and reversible light-
driven nuclear import switch. We hypothesized that it would allow for simple control of genes
of interest in a variety of experimental systems, including multicellular organisms.
Protein engineering in combination with small molecules has previously been used to
control nucleocytoplasmic translocation. Early examples of experimental tools for conditional
nuclear import have used the nuclear hormone receptor Estrogen Receptor α (ERα), which is
cytoplasmic until bound to its ligand. This approach was first applied to control the Myc tran-
scription factor [2], and an improved version that makes use of the estrogen receptor antago-
nist tamoxifen has been widely used for inducing site-specific recombination with the Cre
recombinase (Cre-ERT) [3, 4]. Anchor-Away is a two-component system that works by seques-
tering a protein of interest in the cytosol via rapamycin-dependent heterodimerization between
FKBP12 and the FRB domain of human mTOR kinase. One is fused to a ribosomal protein
and the other to the protein of interest [5]. These approaches rely on the small chemical mole-
cules tamoxifen and rapamycin for induction. Chemical induction requires that small mole-
cules enter cells and biological tissue, has limited reversibility and lacks fine spatial control in
an organism.
Optogenetic tools are minimally invasive, allow for subcellular spatial control, and have re-
versible, rapid and adjustable effects on time scales from milliseconds to hours [6]. Transparent
model organisms such as the nematode C. elegans, the fly D.melanogaster and the zebrafish D.
rerio are especially well suited for optogenetics, and photoactivatable proteins have enabled dis-
coveries in these systems unattainable with conventional techniques [7–9]. Light-activated con-
trol of nuclear import represents a powerful and potentially general way of controlling multiple
cellular functions.
Deiters and co-workers controlled protein localization by incorporating a photoactive
amino acid in a nuclear localization signal so that it could only interact with the nuclear import
machinery when the chemical moiety was removed via irradiation with UV light [10, 11]. This
approach is not reversible and requires the bioavailability of a non-natural amino acid. Equiva-
lent to the Anchor-Away technique is a recently developed organelle targeting system that uses
the red light mediated interaction between phytochrome B (PhyB) and phytochrome-interact-
ing factor 6 (PIF6) [12]. The association and dissociation kinetics of this system are rapid and
it has been used to study the effects of the mitotic cyclin Clb2 in nuclear fission and spindle sta-
bilization in yeast. However, the requirement for a non-natural cofactor (PCB) presents an ob-
stacle to the use of this system in living animals.
Very recently the first fully optogenetic tool for the control of nuclear import was reported
by Niopek and co-workers [13]. The engineered switch makes use of the LOV2 domain from
Avena Sativa (AsLOV2). When activated with blue light, the AsLOV2 domain undergoes a
conformational change and the C-terminal Jα helix unfolds. To control nuclear localization, a
NLS motif was embedded at the end of the Jα helix so that it is sterically hindered from binding
the nuclear import machinery when the AsLOV2 is in its closed, dark-state conformation.
Upon activation with light, the NLS becomes accessible and the protein is imported to the nu-
cleus. To make the switch reversible, a constitutive NES was added to direct the protein to the
cytoplasm when the NLS motif is hidden in the dark state. It was shown that it was important
to tune the relative strengths of the NLS and NES motifs to maximize the dynamic range of the
switch. To demonstrate functional activity, the switch was used to control transcription of a re-
porter gene in mammalian cells.
Here, we confirm and extend the findings of Niopek et al. [13] and present the design, engi-
neering and application of a Light-Activated Nuclear Shuttle (LANS) that also makes use of the
AsLOV2 domain to cage a NLS motif. We directly show that LANS functions by regulating its
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binding affinity to variants of importin α. LANS allows for robust control of transcription in
yeast and exhibits fast blue light-induced nuclear import as well as dark cytoplasmic reversion
in a variety of mammalian tissue culture cells. CRISPR/Cas9-mediated insertion of LANS into
the lin-1 gene of C. elegans conferred light dependence on an endogenous cellular transcription
factor, allowing optogenetic control of vulval cell fate specification in living animals.
Results
Design of a light-conditioned nuclear localization signal
To control nuclear import with light we engineered a conditional Nuclear Localization Signal
(cNLS) that would be allosterically blocked in the dark but available for binding to importin in
the light (Fig 1A). Previously, the AsLOV2 domain from Avena sativa has been successfully
used to control the binding of short, linear sequence epitopes [14–16] and does not contain an
endogenous nuclear localization signal. Therefore, to generate an allosterically caged NLS, we
first attached the human Myc NLS at the end of the AsLOV2 domain after residue 546, aligning
the proline residue from the NLS sequence to the proline residue of AsLOV2. This fusion pro-
tein (AsLOV2cMyc) bound importin α5 with low nanomolar affinity and showed no light-de-
pendence (supplemental). Next, we decided to embed the Myc NLS further into the Jα helix,
aligning the alanine residues present in both sequences (Fig 1B). To eliminate the conserved
proline residue at the beginning of the NLS, which could disrupt the helicity of the Jα, we per-
formed design simulations with the modeling program Rosetta using the karyopherin-Myc
NLS complex structure (PDB: 1EE4). We allowed only the proline residue of the Myc NLS to
vary and identified a favorable methionine substitution (Fig 1B and S1 Fig). Rosetta was then
used to build a model of the designed NLS sequence, grafted onto the AsLOV2 structure (PDB:
Fig 1. Design and biophysical characterization of light conditioned nuclear localization signal. (A)
Schematic of the Light Activated Nuclear Shuttle (LANS) design for light activated nuclear import (B)
Sequence alignment of the wild type AsLOV2 and the designed AsLOV2cNLS (sequence identity and
homology is marked according to CLUSTALW scheme). (C) Fluorescence polarization competitive binding
assay of AsLOV2cNLS against human importin α5 and importin α7.
doi:10.1371/journal.pone.0128443.g001
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2v0u) creating AsLOV2cNLS. The designed methionine pointed towards solvent, not clashing
with any residues from the AsLOV2 domain, and the remaining hydrophobic residues present
in the NLS were well packed against the core PAS domain (S1 Fig).
The switch binds similarly to two distinct importins
Nuclear import efficiency is directly correlated to the binding affinity of a nuclear localization
signal for importin α [17]. To determine the binding affinities of the conditioned NLS for
human importin α, we adopted a competition-based fluorescence polarization assay [14]. We
expressed the AsLOV2cNLS construct and human importins in bacteria, purified them and
measured nanomolar affinities for both importins α5 and α7 under blue light irradiation
(250 nM and 340 nM, respectively). Their affinities in the absence of light decreased to 1.5 μM
for importin α5, and 2 μM for importin α7, which represented a 6-fold change in light/dark af-
finities (Fig 1C and S2 Fig). Since efficient nuclear localization requires an importin binding af-
finity tighter than 1 μM [17], these affinity ranges were predictive of efficient nuclear import
upon light stimulus and reduced translocation in its absence. The similar binding affinities to
two distinct importin α proteins implies that the switch’s nuclear translocation could be medi-
ated by more than one importin in vivo. Lastly, we tested whether the chimeric sequence affects
the AsLOV2 photocycle. We observed that the dark reversion rate of the AsLOV2cNLS does
not deviate from that of wild type AsLOV2, with an activated state half-life of 29.5 sec (S2 Fig).
A Nuclear Export Signal is required for the reversible control of nuclear
import
To determine whether the AsLOV2cNLS switch could control nuclear localization in live cells,
we fused it to mCherry fluorescent protein and observed its sub-cellular distribution in HeLa
cells (Fig 2A). In the dark the mCherry fluorescence intensity was almost evenly distributed
throughout the cells (Fig 2C top leftmost panel). Incorporating a well-studied AsLOV2 point
mutant (I539E) that mimics its lit conformation [18] caused the mCherry signal intensity to
concentrate in the nucleus, validating the switch (Fig 2C bottom leftmost panel). Since the nu-
clear pore complex allows passive diffusion of proteins with molecular weight under 60 kDa
[19, 20], we hypothesized that the observed dark state distribution of the 45 kDa mCherry::
AsLOV2cNLS protein results from passive diffusion throughout the cell, and that adding a nu-
clear export sequence (NES) could shift its distribution to the cytoplasm. Hence, we needed to
identify the appropriate balance between nuclear import and export signal strength, such that a
constitutive NES would be sufficient to remove the switch from the nucleus in the dark but
would be overpowered by the strength of the conditional NLS in the light. We screened a panel
of five NES sequences that vary in export strength and are derived from human nucleocyto-
plasmic shuttling proteins: PKI-α [21], p53 [22], Mdm2 [23], Smad4 [24] and p120ctn [25]
(Fig 2B). We cloned each of the NES sequences between mCherry and either the wild type or
I539E switch variant. For each of the NES variants we quantified the nuclear/cytoplasmic dis-
tribution for either the wild type protein in the dark or the lit mimetic, which allowed us to
measure steady state distributions without concerns about the precise mode and timing of
light stimulation. While the switch with no NES exhibited a 2.64-fold increase in nuclear locali-
zation with the lit mimetic, some amount of protein was always present in the nucleus (Dark
state = 1.35 ± 0.07 nuclear/cytoplasmic fluorescence, n = 10 and Lit mimetic = 3.57 ± 0.20 nu-
clear/cytoplasmic fluorescence, n = 10; Fig 2C and 2D). Three of the NES sequences provided
lower nuclear fluorescence in the dark, p120ctn, PKI-α, and Smad4 (Fig 2C). However, the
NES motif from p120ctn was so strong that nuclear localization was not observed with the lit
mutation. The greatest change in nuclear/cytoplasmic fluorescence (6.2 fold) was observed
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with the NES from Smad4 (Dark state = 0.45 ± 0.02 nuclear/cytoplasmic fluorescence, n = 10
and Lit mimetic = 2.81 ± 0.19 nuclear/cytoplasmic fluorescence, n = 10).
To confirm that exclusion of the constructs from the nucleus required active nuclear export,
we treated cells with the Crm1 inhibitor Leptomycin B [26]. Leptomycin B treatment led to
loss of nuclear exclusion and restoration of the no-NES construct cellular distribution for all
but the p53 and Mdm2 NES (S3 Fig), indicating that the switch constitutively shuttles between
the nucleus and the cytoplasm, and confirming that its nuclear export is mediated by Crm1.
We therefore named the AsLOV2cNLS switch coupled with an NES the Light Activatible Nu-
clear Shuttle (LANS). Here, we refer to different LANS constructs by adding a suffix that de-
notes the NES used: LANS0 carries no NES, while LANS1-5 use the nuclear export signals of
PKI-α, p53, Mdm2, Smad4 and p120ctn, respectively (Fig 2B). LANS remains functional when
short peptide or large globular proteins are fused to its C-terminus (S3 Fig).
Fig 2. Confocal microscopy of LANS in HeLa cells. (A) Schematic of the LANS constructs (B) List of the nuclear export signals tested. (C) Representative
nuclear optical slices of cells used for the quantification of the nuclear/cytoplasmic distribution of the switch (scale bar = 15 μm). (D) Quantification of the
effect of the nuclear export signal on the nuclear/cytoplasmic distribution of LANS (D—wild type construct imaged in the dark, L—lit mimetic I539E). Mean is
reported ±SEM and statistical significance calculated with unpaired two-tailed t-students test; NS—Not Significant.
doi:10.1371/journal.pone.0128443.g002
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LANS is imported and exported within minutes in a variety of mammalian
cell cultures
We next sought to characterize the kinetics of nuclear import and export in response to light
stimulation. We performed blue light stimulation and measured the rates of nuclear import
and dark reversion for LANS4 in three types of mammalian tissue culture cells—HeLa, Cos7
and HEK293 (Fig 3A, 3B and S1–S3 Movies). Nuclear fluorescence upon activation was mea-
sured and fold changes of nuclear accumulation were fit by single exponentials with t1/2 =
3.3 ± 0.02 minutes for HeLa (n = 4), t1/2 = 2.7 ± 0.03 minutes for Cos7 (n = 3) and t1/2 =
5.9 ± 0.01 minutes for HEK293 (n = 5) (Fig 3C). Upon stopping the blue light stimulation, the
nuclear export kinetics were similarly measured and fit, yielding t1/2 = 2.5 ± 0.01 minutes for
HeLa, t1/2 = 2.8 ± 0.02 minutes for Cos7 and t1/2 = 3.2 ± 0.02 minutes for HEK293 (Fig 3C).
The differences observed between the cell types may result from differential expression of
importins and exportins [27]. Nuclear localization appeared fully reversible, with no significant
loss in activation level after multiple cycles of blue light activation and reversion over the course
of a few hours (Fig 3D).
LANS enables robust transcriptional control in yeast
To determine whether LANS could be used to control protein function in cells, we sought
light-mediated control of transcription in yeast. We used the NMY51 yeast strain (Fig 4A) and
an NLS reported plasmid system [28] to which we fused LANS4 to its C-terminus (Fig 4B).
Fig 3. Real time light induced nuclear translocation of LANS4 in mammalian tissue culture cells. (A) Representative images for light activation and
reversion in HeLa cells and Cos7 (B) (scale bar = 25 μm); (c) Plotting the fold change of nuclear accumulations in HeLa, Cos7 and HEK293 (n = 4 each,
mean reported ± SEM with dashed line). See also S1, S2 and S3 Movies. The blue shaded region indicates pulsed blue light activation (see Supplemental
experimental procedures). (C) Multple activation reversion cycles in Cos7 (n = 2, mean reported ± SEMwith shaded grey area). The blue shaded regions
indicate pulsed blue light activation.
doi:10.1371/journal.pone.0128443.g003
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Colony growth assays showed light-dependent survival when grown on media lacking histidine
and adenine with no background detected for the vector (Fig 4C). Normal yeast growth was
not affected by blue light (Fig 4C, left panel: growth minus leucine). We then grew liquid cul-
tures in light and dark and performed β-galactosidase assays to quantify the levels of transcrip-
tional activation. A 21-fold change in signal was observed (8.8 ± 0.7 Miller Units (n = 3) in the
dark and 187 ± 24 Miller Units (n = 3) in the light). No detectable transcription was seen for a
construct with a mutated conditional nuclear localization signal where all lysines and arginines
were substituted with alanines (MAAAAVALD). These data demonstrate that LANS can be
used to control the activity of a transcription factor by regulating its nuclear localization.
LANS can be used to precisely control nuclear translocation in C.
elegans embryos
To test whether LANS can be used to regulate protein nuclear localization in vivo, we took ad-
vantage of the optical clarity and ease of genetic manipulation of the C. elegans embryo. We
fused LANS4 to the red fluorescent protein mKate2 (Fig 5A) and expressed it in C. elegans em-
bryos under the control of the his-72 promoter and tbb-2 3’UTR. This promoter and 3’UTR
support ubiquitous expression throughout development, with the strongest expression in de-
veloping embryos ([29] and D.J.D., unpublished observations). The fusion protein was
Fig 4. Light induced transcription via light mediated nuclear translocation in yeast. (A) NMY51 contains his3, ade2 and lacZ genomic reporter genes
under the control of LexAop. (B) Schematic of the LANS controlled artificial transcription factor in yeast (C) Growth assay of LANS controlled transcription
factor in NMY51. The left panel shows growth on media lacking leucine, which confers plasmid resistance and demonstrates that the light used does not
affect regular yeast growth. The right panel demonstrates light dependent growth on media lacking leucine, histidine and adenine. (D) β-galactosidase
activity measurements upon blue light induced transcription activation with LANS4 n = 3 each, mean reported ± SEM and statistical significance is calculated
with unpaired two-tailed t-student’s test (p = 0.0019).
doi:10.1371/journal.pone.0128443.g004
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cytosolic in embryos kept in the dark, but translocated rapidly (< 2 minutes) into the nucleus
upon blue light activation (Fig 5B and S4 Movie). It returned fast (< 3 minutes) to the cytosol
after the illumination was stopped. Expression and photoactivation of LANS did not appear to
cause toxicity, since the embryos continued developing normally and hatched into viable L1
larvae after the experiment (n = 8 embryos from 2 separate experiments). We next tested
whether we could achieve precise spatial control of nuclear translocation by targeting photoac-
tivation to a single cell. For these experiments, we used embryos expressing mKate2::LANS4 in
mesodermal precursors of the MS cell lineage under the control of the ceh-51 promoter [30]. Il-
lumination of a cell expressing mKate2::LANS4 resulted in rapid nuclear translocation, which
was reversed when the illumination was stopped (Cell 1 in Fig 5C and 5D and S5 Movie). No
change in mKate2::LANS4 localization was detectable in a neighbouring cell that was not illu-
minated (Cell 2 in Fig 5C and 5D and S5 Movie). The activation and recovery curves were well
Fig 5. Light activated nuclear translocation inC. elegans embryo. (A) Schematic of the mKate2::LANS construct that was expressed in C. elegans
embryos (B) Confocal images of an embryo expressing mKate2::LANS ubiquitously and subjected to photoactivation with blue light. Scale bars represent
10 μm. See also S4 Movie. (C) Left: Confocal images of four mKate2::LANS expressing MS lineage cells on the ventral surface of a late gastrulation-stage
embryo. The blue box in the center image indicates the region that was photoactivated with blue light. Brightness and contrast were adjusted to compensate
for photobleaching. Scale bar represents 5 μm. Right: Sketches summarizing the observed localization. Numbers correspond to the cell numbers in (D). See
also S5 Movie. (D) Quantification of nuclear and cytoplasmic fluorescence intensities as a function of time for the two cells labelled in (C). Cell 1 was
illuminated with blue light, and Cell 2 is a neighboring cell. These measurements were corrected for photobleaching (see materials and methods).
doi:10.1371/journal.pone.0128443.g005
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fit by single exponentials with t1/2 = 49 ± 9 seconds for activation and t1/2 = 67 ± 9 for recovery
(n = 11 experiments). We conclude that LANS can be used to control nuclear localization with
high temporal and spatial precision in a living C. elegans.
LANS can be used to manipulate cell fate in vivo
To test whether LANS could be used to control the activity of a protein in vivo, we sought to
manipulate the development of the C. elegans vulva, a classical model system for studying cell
fate specification [31]. During the third larval stage, six vulval precursor cells with equivalent
developmental potential can be induced to adopt either primary or secondary vulval fates in re-
sponse to an EGF signal from the nearby anchor cell. In wild type animals, a single cell called
P6.p receives the strongest EGF signal and adopts the primary vulval fate. Its neighbors, P5.p
and P7.p, adopt the secondary vulval fate in response to a weaker EGF signal from the anchor
cell together with a Notch signal from P6.p [31]. The remaining 3 precursor cells normally
adopt non-vulval fates. Activating mutations in the EGF/Ras/Raf/MAPK signalling pathway
cause ectopic induction of the primary vulval fate, resulting in a Multivulval (Muv) phenotype.
Loss-of-function mutations in this pathway impair vulval induction and cause a Vulvaless
(Vul) phenotype [31].
The LIN-1/ETS transcription factor is a downstream target of the MAPK pathway and is
thought to function as an inhibitor of the primary vulval fate (Fig 6A). Strong lin-1 loss of func-
tion mutations cause all six vulval cells to adopt primary or secondary vulval fates, independent
of the activity of the MAPK pathway, resulting in a strong Multivulval phenotype [32–34].
Conversely, gain of function mutations in lin-1 result in repression of the primary vulval fate
[35]. MAPK phosphorylates LIN-1 on multiple residues in its C-terminal tail (Fig 6B), which
inactivates LIN-1 and allows cells to adopt the primary vulval fate [35].
To generate a light-inducible lin-1 allele, we modified the endogenous lin-1 gene using
Cas9-triggered homologous recombination [36]. We introduced three molecular changes, with
the goal of eliminating the normal regulation of LIN-1 by MAPK and replacing it with optoge-
netic regulation (Fig 6B and S4 Fig). First, we truncated the C-terminus, mimicking the n1790
gain of function allele that eliminates the MAPK docking site and most of the predicted phos-
phorylation sites [35]. Second, we mutated a putative endogenous NLS. Third, we inserted se-
quence encoding mKate2::LANS1. We predicted that the resulting LIN-1::LANS1 fusion
protein would be sequestered in the cytosol and inactive in the dark, but would localize to the
nucleus and be constitutively active in the light.
We examined the phenotypes of lin-1::lans1 animals raised in the dark or under blue light.
Continuous illumination for two days had no effect on the development of wild type animals
(Fig 6C and 6D and DJD, unpublished observations), indicating that the light levels used in
this experiment were non-toxic. A substantial fraction (38%) of lin-1::lans1 animals raised in
the dark exhibited a Multivulval phenotype, consistent with our prediction that LIN-1::LANS1
should have reduced activity in the dark (Fig 6C and 6D). However, it is important to note that
this phenotype is less severe and less penetrant than that of lin-1 null alleles [32–34], suggesting
that LIN-1::LANS1 retains some activity in the dark. This residual activity may be due to shut-
tling activity of LANS (see above), which results in the LIN-1::LANS1 transient nuclear locali-
zation even in the dark.
Illumination with blue light efficiently suppressed the Multivulval phenotype of lin-1::lans1
animals (5%Muv; p = 0.001, Fisher’s exact test), indicating that LIN-1::LANS1 was activated
by blue light. In addition, we observed animals that had, instead of a normal vulval invagina-
tion, a plug of tissue flanked by two smaller-than-normal invaginations (Fig 6C). We interpret
this as a weak Vulvaless phenotype, in which specification of the primary cell fails, but the
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secondary cells still invaginate. This phenotype was observed significantly more frequently in
animals raised under blue light (Fig 6D; 42% vs. 3%; p = 0.0002, Fisher’s exact test), suggesting
that light-activated LIN-1::LANS1 repressed the primary vulval fate, as predicted. Consistent
with our interpretation of the weak Vulvaless phenotype, a small fraction (5%) of lin-1::lans1
animals raised under blue light were completely Vulvaless (Fig 6D). It is important to note that
the n1790mutation, on which lin-1::lans1 was modelled, produces a similarly mild Vulvaless
phenotype, with 54% of n1790 animals showing vulval defects [35]. The penetrance of Vulva-
less / weak Vulvaless phenotypes in lin-1::lans1 animals raised under blue light (54%) is similar
to the penetrance of vulval defects in n1790 animals. Taken together, these data indicate that
Fig 6. Control of vulval development via photoactivatable LIN-1. (A) Simplified schematic of the role of LIN-1 in vulval fate specification. (B) Top:
Schematic of the wild type LIN-1 protein. Bottom: Schematic of the LIN-1::LANS protein produced after modification of the native lin-1 locus using
Cas9-triggered homologous recombination. See also S4 Fig. (C) DIC Images of the developing vulvae in mid-L4 larvae from the indicted strains and
conditions. Top panel: Black arrow indicates the normal, symmetric vulval invagination. Middle panel: Black arrow indicates the main vulval invagination, and
green arrowhead indicates an extra vulval invagination. Bottom panel: Orange arrowheads indicate small invaginations produced by the secondary vulval
precursors, and black arrow indicates the plug of tissue derived from the failed primary cell. Scale bars represent 20 μm. (D) Quantification of phenotypes in
the indicated strains and conditions. See Methods for detailed definitions of each phenotype. Numbers at the top of each bar indicate the total number of
animals scored in this experiment. These data are from a single experiment; the experiment was repeated three times, using two independently isolated lin-
1::lans alleles, with similar results.
doi:10.1371/journal.pone.0128443.g006
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insertion of the LANS1 coding sequence into the lin-1 gene allowed optogenetic control of an
endogenous transcription factor and manipulation of cell fate decisions in a living animal.
Discussion
The LANS switch exhibits light dependent binding to both importin α 5 and importin α 7, in-
dicating that multiple importin α proteins can mediate its nuclear import. Although the switch
accumulates in the nucleus upon light stimulation, in the case of small proteins, passive diffu-
sion through the nuclear pore complex results in even nuclear/cytoplasmic distribution in the
dark. In order to drive the switch out of the nucleus in the dark, we coupled the switch with a
constitutive nuclear export signal, which was shown to require Crm1 for its function. Modulat-
ing the strength of the nuclear export signal permits tuning the nuclear/cytoplasmic distribu-
tion of the protein of interest. The switch is further tunable using previously reported AsLOV2
dark state stabilizing mutations [37]. LANS works in a range of mammalian tissue culture cells
with similar kinetics, which lead to fast nuclear import and cytoplasmic return. It remains
functional after hours of cycled activation and reversion, with the protein returning to initial
nuclear levels when light stimulation is stopped.
In several ways our results provide independent confirmation of the findings of Niopek
et al. [13] in their use of the AsLOV2 domain to control nuclear import. Like us, they found it
necessary to test different NES and NLS signals in order to maximize the dynamic range of
their switch. Their best performing switches showed a ~3-fold change in cytoplasmic/nuclear
protein levels, similar to what we observe. They also observed similar kinetics of nuclear import
and export in mammalian cells with half times near four minutes.
We are aware of no reports of light activated transcription in C. elegans and only four stud-
ies that demonstrate light mediated transcription in multicellular organisms [38–41]. Most
showed activation of specific ectopic reporter genes and required the insertion of a DNA bind-
ing region in the promoter of the gene of interest. This approach is limited to the activation of
a single or a few genes at a time. Only one study demonstrates transcriptional activation of an
endogenous gene in a living organism taking advantage of Cry2 and CIB1 light dimerization
coupled with TALE DNA-binding domain [41]. We created a single component, simple-to-use
switch, which allowed us to apply CRISPR/Cas9-triggered homologous recombination for di-
rect, single-step control of an endogenous transcription factor and, we infer based on resulting
phenotypes, its set of gene targets. Consequently, we were able to trigger a systemic cellular re-




All cloning PCR amplifications were performed using high-fidelity Q5 polymerase and all pre-
liminary construct screens were carried out by colony PCR using Taq polymerase. All enzymes
were purchased from New England Biolabs (NEB). All plasmids were verified by DNA se-
quencing (GeneWiz).
Light illumination setup
The illumination setup for the fluorescence polarization assays was as described in Lungu et al,
2012. Briefly, collimated blue LED with maximum emission at 455 nm (Thorlabs) provided 6
mW/cm2 illumination to a sample in a 1 cm quartz cuvette.
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For the S. cerevisae and C. elegans experiments, a LED strip with maximum emission at 465
nm (Mouser Electronics, cat. #: 901-SB-0465-CT) was placed in an array 25 x 35 cm, 15 cm
above the samples in an incubator set at 30°C for yeast and 20°C for C. elegans, thus obtaining
even illumination of ± 500 μW/cm2 for yeast and ± 250 μW/cm2 for C. elegans.
Protein expression
Avena sativa phototropin-1 gene corresponding to residues 404–546 encoding for the LOV2
domain (Uniprot: O49003) was amplified with two-step overlap extension PCR introducing
the designed nuclear localization signal and clone in pQE-80L using BamHI and HindIII re-
striction digest. The resulting plasmid was transformed in BL21 (DE3) pLysS and bacteria
grown in 1.5 L Luria Bertani media till reaching OD600 ~ 0.6 upon which protein production
was induced with 500 mM IPTG overnight (18-20h) at 25°C. Cell pellets were resuspended in
50 mM Tris pH 7.5, 1 M NaCl, 10 mM Imidazole, 10 mM β-ME and 1 mM PMSF and sonicat-
ed for 15 mins (5 sec. ON, 5 sec. OFF) on ice at 4°C. Lysed cells were then centrifuged for
30 min at 18564 RCF, then the supernatant filtered through 5 μM filter and loaded on 5 mL
HisTrap IMAC columns (GE Healthcare). The columns were washed with 30 CV of 50 mM
Tris pH 7.5, 1 M NaCl, 10 mM Imidazole, 10 mM β-ME and eluted on BioLogic LP (BioRad)
using a gradient against 50 mM Tris pH 7.5, 100 mMNaCl, 500 mM Imidazole, 10 mM β-ME.
The eluted protein was concentrated with Amicon Ultra-15 (Millipore) to 2 mL and subjected
to size exclusion chromatography in 50 mM Tris pH 7.5, 100 mMNaCl and 1 mM DTT with
HiLoad 16/600 Superdex 75 (GE Healthcare) run on Akta FPLC (Amersham). Importins were
expressed and purified in the same way as described above. After IMAC the proteins were con-
centrated to 5 mL, dialyzed against 5 L of 50 mM Tris pH 7.5 overnight at 4°C and purified
over HiTrap Q HP column (GE Healthcare) eluted over a gradient against 50 mM Tris pH 7.5
and 1 M NaCl. Then, the protein was were concentrated to 5 mL and subjected to size exclu-
sion chromatography in 50 mM Tris pH 7.5, 100 mMNaCl and 1 mM DTT with HiLoad 16/
600 Superdex 200 (GE Healtchare). All protein concentrations were determined using the BCA
assay following manufacture protocol (Thermo Scientific Pierce).
Fluorescence polarization
Peptide of the following sequence GDMAAKRVKLD was synthesized at UNC- Chapel Hill
and amine labeled using 5- and 6-Carboxytetramethylrhodamine (TAMRA) dye. Peptide con-
centration was determined by measuring absorbance of the TAMRA dye at 555 nm using
65,000 M-1 cm-1 as extinction coefficient. All fluorescence polarization measurements were
performed on FluoroMax3 (Jobin Ybon Horiba) fluorescence spectrometer using 25 nM of the
TAMRA labelled peptide in 3 mL of 50 mM Tris pH 7.5, 100 mMNaCl and 1 mMDTT. The
dye was excited with polarized light at 555 nm and polarization of emitted light measured at
584 nm. The sample was held in a 1 cm quartz cuvette at 25°C, increasing concentrations of
importin α were titrated and two polarization values for dark and lit state binding were re-
corded for each titration point. The polarization value for the lit state binding was collected
after 2 minutes of blue light illumination and for the dark state by another measurement taken
after 5 minutes in absence of light for the same titration point. Finally, the competition was fit
for one-site total binding with Prism 5 (GraphPad) and IC50 values were used to determine
the Kd with the online calculator [42].
Mammalian cell culture
HeLa, Cos7 HEK293T (ATCC) tissue cultures were grown at 37°C, 10% CO2 in DMEM sup-
plemented with 10% (v/v) HyClone Standard Fetal Bovine Serum (Thermo Scientific) and 1%
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(v/v) GlutaMAX (GIBCO). Cells were passaged every 2–3 days usually in Nunc T-25 or T-75
culture flasks (Thermo Scientific).
Mammalian cell imaging
Constructs consisting of mCherry and AsLOV2cNLS with or without NES signals located be-
tween mCherry and AsLOV2cNLS were cloned in pTriEx with restriction digest cloning using
NcoI and HindIII restriction sites. All constructs were sequence verified.
Coverslips were washed with PBS (GIBCO) and coated with 10 μg/ml fibronectin at room
temperature for a minimum of 1.5 hours. Cells were seeded for a minimum of 3 hours to over-
night, then transfected using FuGENE 6 (Promega) and imaged after about 18 hours post-
transfection in Ham’s F-12K medium free of Phenol red (Caisson) and containing 10% FBS
buffered with 10 mMHEPES pH 8. Coverslips were mounted in an Attofluor live cell chamber
(Invitrogen) placed in a microscope stage with a heated stage adaptor (Warner) and an objec-
tive temperature controller (Bioptechs).
An Olympus DSU-IX81 Spinning Disk Confocal coupled with Andor solid-state lasers
(Andor) was used to perform the nuclear export signal screen. Z-stacks of 12 μm at 0.5 μm
steps were acquired with a PlanApo 60× objective (Oil, N.A. 1.42) using a 561 nm laser set at
20% intensity (150 EM gain and 300 ms exposure).
Live cell timelapse series were collected with an Olympus IX81 epifluorescence microscope
equipped with a ZDC focus drift compensator and a Photometrics CoolSnap ES2 CCD camera
(Roper Photometrics). A UPlanFLN 40× objective (Oil, N.A. 1.30) was used with an ET572/
35x filter for mCherry detection and 1% (UVND 2.0, ET430/24x) for blue light activation of
LANS.
Yeast transcription
LANS4 was amplified and cloned into pNIA-CEN-MBP plasmid [28] using EcoRI and BamHI
restriction sites. The resultant plasmid was transformed via high efficiency lithium acetate
transformation [43] and plated on SC-Leucine droupout agar plates.
Survival assays were performed as follows: Fresh colonies were grown overnight at 30°C in 5
ml SC-Leucine. On the next day, the cell density was measured at OD600 and cultures diluted
in 200 μl of OD600 = 1, followed by 8 5-fold serial dilutions. Then, 5 μl of each of the dilutions
were pipetted and spotted using a multichannel pipette (Gilson) onto respective dropout plates.
The dark condition plates were wrapped in aluminium foil and placed in the same incubator as
the lit condition at 30°C. Blue light (465 nm) at 500 μW/cm2 was provided with LED strip
lights attached at the incubator (look at illumination settings). Yeast plates were scanned after
72h incubation using an HP ScanJet 4850 scanner and resulting images were cropped and ar-
ranged using Adobe Photoshop.
β-Galactose assay were performed as follows: Fresh colonies were grown overnight at 30°C
in 5 ml SC-Leucine. On the next day, the cell density was measured at OD600 and 2 mL cultures
were diluted to OD600 = 0.2 in duplicates—one for a light and another for a dark condition
(falcon tubes were wrapped in aluminium foil). Cultures were grown at 30°C in a shaking incu-
bator (250rpm) till reaching OD600 ± 0.8 in presence or absence of blue light (465 nm) at
500 μW/cm2 via LED strip light wrapped around the tube rack. The resulting cultures were pel-
leted in triplicates and β-Galactose assay using CPRG for a substrate was performed according
to the manufacturer (Clontech).
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C. elegans culture and strain construction
S1 Table lists the C. elegans strains used in this study including the native N2 [44]. All strains
were maintained at 20°C or 25°C on NGMmedium, using E. coli strain OP50 as a food source.
To express mKate2::LANS4 ubiquitously in early embryos, an mKate2::LANS4 coding se-
quence was designed using optimal C. elegans codons and synthetic introns [45]. This sequence
was assembled from gBlocks gene fragments (Integrated DNA Technologies) using Gibson as-
sembly (New England BioLabs) and cloned into a modified pCFJ352 vector [46] containing the
his-72 promoter and tbb-2 3’UTR. This construct was inserted as a single-copy transgene into
the ttTi4348 locus on LG I using MosSCI [46]. To express mKate2::LANS4 in MS cells, a con-
struct carrying the mKate2::LANS coding sequence was cloned into a modified pCFJ151 vector
[46] containing the ceh-51 promoter and tbb-2 3’UTR. This construct was injected into wild
type worms (strain N2) to generate extrachromosomal arrays [47].
To insert LANS1 into the lin-1 locus, we used Cas9-triggered homologous recombination
[36]. S4 Fig shows a schematic of our gene targeting strategy. We modified the Cas9–sgRNA
expression plasmid pDD162 by inserting the guide sequence ATGACGTCGTGGAGGGC
GATA. Next, we constructed a homologous repair template by first cloning a 3.9 kb genomic
fragment, comprising the last 3.3 kb of the lin-1 gene followed by a 0.2 kb intergenic region and
the first 0.5 kb of the downstreamM70.5 gene, into the pCR-Blunt TOPO vector. We made 4
modifications to this construct: 1) We deleted a 1 kb fragment comprising the last 270 bp of
lin-1 coding sequence and an intervening intron, and replaced this fragment with the
mKate2::LANS1 coding sequence. 2) We mutated the putative NLS sequence RQCRKRSL to
AQCAAASL. 3) We inserted a selection cassette, comprising a hygromycin resistance gene
[48] followed by unc-58(n495), into the intergenic region downstream of the lin-1 3’UTR. We
intended to use the dominant Unc-58 phenotype as a visible marker for the lin-1 allele, but ani-
mals generated using this construct do not have an Unc-58 phenotype, indicating that, al-
though unc-58(n495) is a dominant mutation, insertion of a single extra copy of unc-58(n495)
into an unc-58(+) background is not sufficient to cause the Unc-58 phenotype. 4) Finally, be-
cause lin-1 andM70.5 are close together and located on the same strand, it is possible that the
lin-1 3’UTR contains sequences that function in the promoter ofM70.5, and that insertion of
the selectable marker in the intergenic region between lin-1 andM70.5 could disruptM70.5 ex-
pression. To avoid this, we inserted a second copy of the lin-1 3’UTR downstream of the select-
able marker. The sequence of the final homologous repair template is available upon request.
The elk-2 gene of C. elegans has>90% nucleotide sequence identity to the region of lin-1
that we wished to modify, which made it impossible to identify a Cas9 target site that was
unique to lin-1. Therefore, to avoid inadvertently modifying elk-2 instead of lin-1, we per-
formed Cas9-triggered homologous recombination in the parent strain VC2110, which carries
a deletion in elk-2 that removes part of the region homologous to lin-1, including the Cas9 tar-
get site that we selected. An injection mix containing 50 ng/μL Cas9–sgRNA plasmid, 10 ng/μL
homologous repair template, and co-injection markers [36] was injected into young VC2110
adults. The injected animals were allowed to lay eggs for 3 days at 25°C, and then hygromycin
was added to the plates to a final concentration of 0.5 mg/mL to kill non-transformed animals.
After 7 days of selection, the plates were heat shocked for 4h at 34°C to kill animals carrying ex-
trachromosomal arrays (via PEEL-1 negative selection [46]). Candidate lin-1::lans animals that
survived both rounds of selection were singled to establish lines, and correct insertion of lans
was confirmed by PCR. We then outcrossed to remove the unlinked elk-2mutation that facili-
tated strain construction.
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Photoactivation experiments in C. elegans embryos
Embryos expressing mKate2::LANS4 were mounted on polylysine-coated coverslips and gently
flattened using 2.5% agar pads. For whole-embryo photoactivation experiments (Fig 5B), we
used a Nikon Eclipse Ti microscope equipped with a 100X, 1.49 NA objective and a Yokagawa
CSU-X1 spinning disk head and controlled using Metamorph (Molecular Devices). Confocal
images of mKate2 fluorescense were captured every 10s, and the embryos were illuminated
with ~180 μW/cm2 of blue light from a 488 nm laser for 5s between each pair of image acquisi-
tions (i.e., 50% photoactivation duty ratio). For single-cell photoactivation experiments (Fig
5C), we used a Zeiss LSM710 laser scanning confocal microscope equipped with a 100X, 1.3
NA objective and controlled by Zeiss Zen software. Images were acquired at 10s intervals, and
photoactivation was done between each pair of acquisitions by scanning a 458 nm laser at ~170
W/cm2 over a region of interest defined using the FRAP/photoactivation function of the Zen
software. Each pixel was illuminated for a total of 63 μs during photoactivation.
To measure mKate2::LANS4 nuclear localization, we made line scans across a region of the
image that encompassed the nucleus and cytoplasm of each cell of interest. Pixel intensities
were measured from kymographs and converted to fluorescence intensity by subtracting off-
embryo background. To correct for photobleaching, we normalized each measurement to the
total integrated fluorescence intensity of the entire image.
Scoring of vulval phenotypes
Animals were synchronized by allowing embryos to hatch in the absence of food and arrest as
L1 larvae. Synchronized larvae were plated on NGM plates seeded with E. coli OP50, and the
plates were placed under blue LED illumination (see above). Dark controls were placed in the
same incubator and wrapped in aluminium foil to prevent light exposure. When the animals
reached mid-L4 stage (approximately 48 hours), they were mounted on 2.5% agar pads con-
taining 10 mM sodium azide as a paralytic. DIC images of the developing vulva were acquired
using a Nikon Eclipse E800 microscope equipped with Nomarski optics and a 100X, 1.4 NA
objective. Animals were scored as Normal if there was a single, symmetric vulval invagination;
as Multivulval if they had at least one secondary invagination in addition to the main vulva; as
“weak Vulvaless” if, instead of a fully formed vulval invagination, there were two small, equal-
ly-sized invaginations separated by apparently undifferentiated tissue; as Vulvaless if there was
no vulval invagination; and as Deformed if there was a single vulval invagination that was mis-
shapen or asymmetric, or if the morphology was too abnormal to be confidently assigned to
one of the other categories. Data were plotted and p values were calculated using Graphpad
Prism software.
Accession codes
Addgene: pTriEx-mCherry::LANS1, 60784; pTriEx-mCherry::LANS4, 60785.
Supporting Information
S1 Fig. LANS computational design. (A) Rosetta model of the designed NLS on yeast karyo-
pherin (B) Rosetta model of the chimeric AsLOV2cNLS.
(TIF)
S2 Fig. Biophysical characterization of LANS. (A) Peptide binding to importin α 5 and (B)
importin α 7 (C) AsLOV2 native sequence does not compete with an NLS for binding to α 5
and α 7 in neither dark nor light conditions (D) Fusing the Myc NLS directly at the C-terminus
of AsLOV2 (PDB: 2v0u) residue 546 leads to tight but light independent binding to importin α
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5 with affinities measured at about 1 nM. (E) AsLOV2cNLS chimera preserves wild type
AsLOV2 reversion kinetics.
(TIF)
S3 Fig. LANS is actively exported and tolerates small and large C-terminal fusions. (A)
Treatment with 200 nM of Leptomycin B for 10 minutes reverts the nuclear/cytoplasmic distri-
bution of LANS with NES signals to one without a nuclear export signal. Confocal microscopy
with a single nuclear optical slice (scale bar 15 μm) (B) C-terminal fusion of a short peptide
(flag tag) and large globular protein (MBP) constructs. (C) Epifluorescent microscopy for flag
tag and MBP in the dark and after 10 minutes of blue light activation (scale bar 25 μm).
(TIF)
S4 Fig. Cas9-triggered homologous recombination schematic. Schematic of our strategy for
modifying the lin-1 locus using Cas9-triggered homologous recombination. See Experimental
procedures for details.
(TIF)
S1 Movie. mCherry::LANS4 blue light activation and reversion in HeLa. Still images from
this movie are shown in Fig 4A. The scale is provided with a scale bar = 25 μm, the time is
shown as min:sec and “ON” indicates intermittent blue light activation (see Supplemental ex-
perimental procedures).
(MOV)
S2 Movie. mCherry::LANS4 blue light activation and reversion in Cos7. Still images from
this movie are shown in Fig 4B. The scale is provided with a scale bar = 25 μm, the time is
shown as min:sec and “ON” indicates intermittent blue light activation (see Supplemental ex-
perimental procedures).
(MOV)
S3 Movie. mCherry::LANS4 blue light activation and reversion in HEK293. The scale is pro-
vided with a scale bar = 25 μm, the time is shown as min:sec and “ON” indicates intermittent
blue light activation (see S1 Text).
(MOV)
S4 Movie. Whole-embryo photoactivation of ubiquitously expressed mKate2::LANS4. Still
images from this movie are shown in Fig 5B.
(MOV)
S5 Movie. Photoactivation of mKate2::LANS4 in a single MS cell. Still images from this
movie are shown in Fig 5C.
(MOV)
S1 Table. C. elegans strains used in this study.
(XLSX)
S1 Text. Supporting Materials and Methods.
(PDF)
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